Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements. | Front Cell Dev Biol | 2023 | 37920823 | PubTator, text mining | PubMed |
| Associations between genetically predicted sex and growth hormones and facial aging in the UK Biobank: a two-sample Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 37916150 | PubTator, text mining | PubMed |
| Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan. | BMC Cancer | 2023 | 37904096 | PubTator, text mining | PubMed |
| Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. | Life (Basel) | 2023 | 37895357 | PubTator, text mining | PubMed |
| Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments. | Cancers (Basel) | 2023 | 37894414 | PubTator, text mining | PubMed |
| Recurrent Chemotherapy Treated Indeterminate Dendritic Cell Tumor: Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2023 | 37881204 | PubTator, text mining | PubMed |
| Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology. | Medicine (Baltimore) | 2023 | 37861538 | PubTator, text mining | PubMed |
| MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis. | Front Oncol | 2023 | 37854681 | PubTator, text mining | PubMed |
| Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. | EBioMedicine | 2023 | 37837931 | PubTator, text mining | PubMed |
| A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis. | Heliyon | 2023 | 37809372 | PubTator, text mining | PubMed |
| Selenium in Prostate Cancer: Prevention, Progression, and Treatment. | Pharmaceuticals (Basel) | 2023 | 37765058 | PubTator, text mining | PubMed |
| Spindle Cell Rhabdomyosarcoma of the Inguinal Region Mimicking a Complicated Hernia in the Adult-An Unexpected Finding. | Medicina (Kaunas) | 2023 | 37763635 | PubTator, text mining | PubMed |
| Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials. | Cancers (Basel) | 2023 | 37760551 | PubTator, text mining | PubMed |
| Allo: Accurate allocation of multi-mapped reads enables regulatory element analysis at repeats. | bioRxiv | 2023 | 37745557 | PubTator, text mining | PubMed |
| Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review). | Int J Oncol | 2023 | 37732538 | PubTator, text mining | PubMed |
| Clinical diagnostic and radiographic features of a primary intradural spinal chondrosarcoma in a young adult: illustrative case. | J Neurosurg Case Lessons | 2023 | 37728306 | PubTator, text mining | PubMed |
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study. | Cancer Med | 2023 | 37724607 | PubTator, text mining | PubMed |
| Analysis of the mechanism of action of Euphorbia fischeriana Steud on cirrhosis based on network pharmacology. | Medicine (Baltimore) | 2023 | 37713886 | PubTator, text mining | PubMed |
| Insights into vitamin A in bladder cancer, lack of attention to gut microbiota? | Front Immunol | 2023 | 37711628 | PubTator, text mining | PubMed |
| Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets. | Nat Commun | 2023 | 37704626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=8